Rapposelli S

References (4)

Title : Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease - Chen_2017_Eur.J.Med.Chem_125_784
Author(s) : Chen Z , Digiacomo M , Tu Y , Gu Q , Wang S , Yang X , Chu J , Chen Q , Han Y , Chen J , Nesi G , Sestito S , Macchia M , Rapposelli S , Pi R
Ref : Eur Journal of Medicinal Chemistry , 125 :784 , 2017
Abstract :
PubMedSearch : Chen_2017_Eur.J.Med.Chem_125_784
PubMedID: 27736684

Title : Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease - Nesi_2017_Eur.J.Med.Chem_141_232
Author(s) : Nesi G , Chen Q , Sestito S , Digiacomo M , Yang X , Wang S , Pi R , Rapposelli S
Ref : Eur Journal of Medicinal Chemistry , 141 :232 , 2017
Abstract :
PubMedSearch : Nesi_2017_Eur.J.Med.Chem_141_232
PubMedID: 29031070

Title : Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD - Digiacomo_2015_Bioorg.Med.Chem.Lett_25_807
Author(s) : Digiacomo M , Chen Z , Wang S , Lapucci A , Macchia M , Yang X , Chu J , Han Y , Pi R , Rapposelli S
Ref : Bioorganic & Medicinal Chemistry Lett , 25 :807 , 2015
Abstract :
PubMedSearch : Digiacomo_2015_Bioorg.Med.Chem.Lett_25_807
PubMedID: 25597007

Title : Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease - Chao_2012_Bioorg.Med.Chem.Lett_22_6498
Author(s) : Chao X , He X , Yang Y , Zhou X , Jin M , Liu S , Cheng Z , Liu P , Wang Y , Yu J , Tan Y , Huang Y , Qin J , Rapposelli S , Pi R
Ref : Bioorganic & Medicinal Chemistry Lett , 22 :6498 , 2012
Abstract :
PubMedSearch : Chao_2012_Bioorg.Med.Chem.Lett_22_6498
PubMedID: 22981331